Review





Similar Products

94
Selleck Chemicals cabozantinib xl 184
Cabozantinib Xl 184, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/xl+184/Cabozantinib/pm40829740-69-0-29
Average 94 stars, based on 1 article reviews
cabozantinib xl 184 - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

90
LC Laboratories cabozantinib xl-184 lc-c-8901
Cabozantinib Xl 184 Lc C 8901, supplied by LC Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/xl+184/cabozantinib/pmc11560812-58-4-7
Average 90 stars, based on 1 article reviews
cabozantinib xl-184 lc-c-8901 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Exelixis cabozantinib xl-184
Cabozantinib Xl 184, supplied by Exelixis, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/xl+184/xl184/10__26420_slash_austinjpharmacolther__2023__1178-99-0-11
Average 90 stars, based on 1 article reviews
cabozantinib xl-184 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Exelixis cabozantinib/xl-184/bms-907351
Cabozantinib/Xl 184/Bms 907351, supplied by Exelixis, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/xl+184/xl184/us11607421-106-23-26
Average 90 stars, based on 1 article reviews
cabozantinib/xl-184/bms-907351 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Exelixis cabozantinib (xl-184
Cabozantinib (Xl 184, supplied by Exelixis, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/xl+184/xl184/pmc03514064-300-20-22
Average 90 stars, based on 1 article reviews
cabozantinib (xl-184 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Exelixis xl-184
Kinase inhibitor drugs * with associated RET profile, classification, and FDA indication 24
Xl 184, supplied by Exelixis, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/xl+184/xl184/pmc09697126-401-20-7
Average 90 stars, based on 1 article reviews
xl-184 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

Image Search Results


Kinase inhibitor drugs * with associated RET profile, classification, and FDA indication 24

Journal: Journal of medicinal chemistry

Article Title: Targeting rearranged during transfection (RET) in Cancer: A perspective on small molecule inhibitors and their clinical development

doi: 10.1021/acs.jmedchem.0c02167

Figure Lengend Snippet: Kinase inhibitor drugs * with associated RET profile, classification, and FDA indication 24

Article Snippet: Cabozantinib (Cometriq ® , XL-184), developed by Exelixis, is a VEGFR2 selective inhibitor with additional activities against RET, MET, FLT3, c -KIT, AXL, and Tie-2 ( in-vitro kinase inhibition profile is demonstrated in ).

Techniques:

Comparative kinase inhibitory profile of first generation MKIs

Journal: Journal of medicinal chemistry

Article Title: Targeting rearranged during transfection (RET) in Cancer: A perspective on small molecule inhibitors and their clinical development

doi: 10.1021/acs.jmedchem.0c02167

Figure Lengend Snippet: Comparative kinase inhibitory profile of first generation MKIs

Article Snippet: Cabozantinib (Cometriq ® , XL-184), developed by Exelixis, is a VEGFR2 selective inhibitor with additional activities against RET, MET, FLT3, c -KIT, AXL, and Tie-2 ( in-vitro kinase inhibition profile is demonstrated in ).

Techniques:

Kinase inhibition profile of nintedanib 191

Journal: Journal of medicinal chemistry

Article Title: Targeting rearranged during transfection (RET) in Cancer: A perspective on small molecule inhibitors and their clinical development

doi: 10.1021/acs.jmedchem.0c02167

Figure Lengend Snippet: Kinase inhibition profile of nintedanib 191

Article Snippet: Cabozantinib (Cometriq ® , XL-184), developed by Exelixis, is a VEGFR2 selective inhibitor with additional activities against RET, MET, FLT3, c -KIT, AXL, and Tie-2 ( in-vitro kinase inhibition profile is demonstrated in ).

Techniques: Inhibition